Contracts › 36C26226N0112
36C26226N0112: Pluvicto and Lutathera
Awarded to Novartis Pharmaceuticals Corporation by Department of Veterans Affairs.
$4.3Mobligated
$4.3Mpotential value
30 November 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 36C26226N0112 |
|---|---|
| Vehicle | 36F79720D0180 |
| Awardee | Novartis Pharmaceuticals Corporation |
| Awarding agency | Department of Veterans Affairs |
| Awarding office | 262-NETWORK CONTRACT OFFICE 22 (36C262) |
| NAICS | 325412 Pharmaceutical Preparation Manufacturing |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | NJ |
| Offers received | 1 |
| Period of performance | 01 November 2025 to 30 November 2026 |
| Potential end | 30 November 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 18 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325412 contracts · All expiring contracts · USASpending record